Menu

Website Search

Zaltrap.com

zaltrap.com
Visit zaltrap.com

  • 1 week ago

    Last scanned

  • 15 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Zaltrap.com

Visit zaltrap.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Metastatic Colorectal Cancer (mCRC) Treatment | ZALTRAP® (ziv-aflibercept)

ZALTRAP is a cancer drug given with chemotherapy (FOLFIRI) for mCRC patients previously treated with oxaliplatin. See Important Safety Information and full Prescribing Information including Serious Side Effects.

Zaltrap.com thumbnail
Zaltrap.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for zaltrap.com: 18.165.98.10, 18.165.98.102, 18.165.98.115, 18.165.98.124. Moreover, DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com. Subnet identifier ranges from 18.164.0.0 to 18.165.255.255. Classless Inter-Domain Routing (CIDR) is 18.164.0.0/15. ARIN net type is Reallocated.

  • 1 week ago

    Last scanned

  • 15 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of zaltrap.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2025-05-07. According to open source data, you can reach the owner at domain.names@sanofi.com but please make sure you have a good reason for unsolicited messages. Their country of residence is France, French Republic.

  • zaltrap
  • regorafenib
  • ramucirumab
  • metastatic colorectal cancer treatment
  • ziv-aflibercept
  • metastatic colorectal cancer medicine
  • ziv aflibercept

Websites similar to zaltrap.com